ID
25295
Beschreibung
Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease
Stichworte
Versionen (2)
- 31.08.17 31.08.17 -
- 04.09.17 04.09.17 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
31. August 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Patient's Daily Study Drug Diary determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
Patient's Daily Study Drug Diary determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
Beschreibung
CONCOMITANT MEDICATIONS
Alias
- UMLS CUI-1
- C2347852
Ähnliche Modelle
Patient's Daily Study Drug Diary determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
C0013227 (UMLS CUI [1,2])
C0332170 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,2])
C1883727 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0332170 (UMLS CUI [2,2])
C0237753 (UMLS CUI [1,2])
C1883727 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0332170 (UMLS CUI [2,2])
C0237753 (UMLS CUI [1,2])
C1883727 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0332170 (UMLS CUI [2,2])
C0237753 (UMLS CUI [1,2])
C1883727 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0332170 (UMLS CUI [2,2])
C0013227 (UMLS CUI [1,2])
C0585020 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,2])
C1883727 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0585020 (UMLS CUI [2,2])
C0013227 (UMLS CUI [1,2])
C0587117 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,2])
C1883727 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0587117 (UMLS CUI [2,2])